|Welcome to the
web site of Prof. Dr. Süreyya Ölgen!
Her current study
is design and synthesis of several indole and pyrrolopyrimidine
compounds as tyrosine kinase and hyaluronidase inhibitors for the
treatment of cancer. Previous efforts were focused on the design and
synthesis of several indole derivatives for their antibacterial,
anti-oxidant and COX-2 selective inhibitory activities. Some
nucleeoside analogs were designed and synthesized against HIV, HBV and
other viral infectious. Furthermore, several imidazolyl substitited
biphenyl compounds were syntesized as 17-Alfa-Hydroxylase-C-17,
20-Lyase (P450 17) inhibitors for the tratment of prostate cancer.
Please click the
on the left hand side for more